Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SunCo Green is an Australian private medical cannabis company founded in 2020 and based on the Sunshine Coast, Queensland. The company focuses on supplying prescription medicinal cannabis products to the Australian market and positions itself as a locally owned pharmaceutical business serving patients and healthcare professionals. Publicly available information indicates it secured medicinal cannabis and cannabis manufacturing licences for facilities in Queensland and South Australia, and it has relied on external GMP manufacturing and supply relationships, including MediPharm Labs, to bring products to market. The business appears to be commercial-stage rather than a traditional clinical-development biotech, with limited evidence of a disclosed R&D pipeline of novel drug candidates. Its activities are centered on commercialization, product access, and educational support through its medical portal rather than proprietary target-driven drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sunco Green Pharmaceutical.